Web Results

Aprepitant

en.wikipedia.org/wiki/Aprepitant

Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the ...

EMEND® (aprepitant) 80 mg, 125 mg capsules EMEND ...

www.emend.com/

The Merck Access Program can help answer your questions about: insurance coverage for patients, benefit investigations, prior authorizations, appeals, and ...

Aprepitant: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/aprepitant.html

Easy to read patient leaflet for aprepitant. Includes indications, proper use, special instructions, precautions, and possible side effects.

DrugBank: Aprepitant

www.drugbank.ca/drugs/DB00673

Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the  ...

Aprepitant: a review of its use in the prevention of chemotherapy ...

www.ncbi.nlm.nih.gov/pubmed/15025555

Oral aprepitant, in combination with other agents, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) ...

aprepitant oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

www.webmd.com/drugs/2/drug-75031/aprepitant-oral/details

Find patient medical information for aprepitant oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Emend - Merck.com

www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf

and effectively. See full prescribing information for EMEND. CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use.

FDA Approves Pediatric Indication for EMEND® (aprepitant ...

www.mercknewsroom.com/news-release/oncology-newsroom/fda-approves-pediatric-indication-emend-aprepitant-capsules-combinati

Sep 2, 2015 ... The FDA approval of this expanded indication for EMEND (aprepitant) was based in part on findings from a randomized, double-blind, ...

Aprepitant: A substance P antagonist for chemotherapy induced ...

www.indianjcancer.com/article.asp?issn=0019-509X;year=2007;volume=44;issue=1;spage=25;epage=30;aulast=Girish

Aprepitant, a drug that antagonizes the effect of substance P on neurokinin type 1 receptor showed promising results in controlling both phases of CINV.

EMEND 80mg, 125mg hard Capsules - Summary of Product ...

www.medicines.org.uk/emc/medicine/13868

Apr 11, 2016 ... Each 125 mg capsule contains 125 mg of aprepitant. Each 80 mg capsule contains 80 mg of aprepitant. Excipient with known effect.

More Info

Aprepitant: MedlinePlus Drug Information

medlineplus.gov

Apr 15, 2016 ... Aprepitant is used with other medications to prevent nausea and vomiting that may occur within 24 hours after receiving cancer chemotherapy ...

Emend Capsules (Aprepitant Capsules): Side Effects, Interactions ...

www.rxlist.com

EMEND capsules contain the active ingredient, aprepitant. Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist, an antiemetic agent, chemically ...

APREPITANT - ORAL (Emend) side effects, medical uses, and drug ...

www.medicinenet.com

Consumer information about the medication APREPITANT - ORAL (Emend), includes side effects, drug interactions, recommended dosages, and storage ...